The drug maker Merck drafted dozens of research studies for a best-selling drug, then lined up prestigious doctors to put their names on the reports before publication, according to an article to be published Wednesday in a leading medical journal.
The article, based on documents unearthed in lawsuits over the pain drug Vioxx, provides a rare, detailed look in the industry practice of ghostwriting medical research studies that are then published in academic journals.
Merck Wrote Drug Studies For Doctors
Last week, with an assist from first lady Michelle Obama, the Food and Drug Administration announced...
More than half of U.S. hospitalized patients get an antibiotic and health officials say a strong...
